Top Markets
Coin of the day
Kindstar Globalgene Technology, Inc. Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc.

9960
株式のランク #20738
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly... Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research, clinical drug trials, and translational medicine initiatives for a diverse client base, including individual practitioners, research organizations, various hospital types, and pharmaceutical firms. This broad service portfolio is underpinned by its extensive, state-of-the-art laboratory infrastructure, which encompasses disciplines such as flow cytometry, cytogenetics, medical genomics, molecular biology, hematopathology, mass spectrometry, pathology, clinical immunology, and microbiology, alongside dedicated scientific research labs. Kindstar Global offers a comprehensive range of diagnostic tests covering key areas like hematology (blood), oncology (tumor), and genetic disorders. Its capabilities also extend to diseases affecting the cardiovascular and cerebrovascular systems, infectious agents, and autoimmune conditions, supporting various medical specialties including internal medicine, surgery, gynecology, pediatrics, and numerous other clinical fields. Established in 2003, the company maintains its headquarters in Wuhan, China.
株価
$0.11769213
時価総額
$121.61M
変化(1日)
-0.54%
変化(1年)
-45.26%
CN
取引 Kindstar Globalgene Technology, Inc. (9960)

カテゴリー

Kindstar Globalgene Technology, Inc.(9960)の利益
2026 時点の利益 TTM: 0
Kindstar Globalgene Technology, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Kindstar Globalgene Technology, Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益